Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Chronic Lymphocytic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01889186
What this trial is testing

The Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion

Who this might be right for
Chronic Lymphocytic Leukemia17p DeletionCancer of the Blood and Bone Marrow
AbbVie 158
Not applicableStudy completedNCT05665374
What this trial is testing

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Who this might be right for
Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
AstraZeneca 67
Not applicableActive Not RecruitingNCT02414022
What this trial is testing

Economic Analysis of Alliance A041202 CLL Study

Who this might be right for
Chronic Lymphocytic Leukemia
Canadian Cancer Trials Group 55
Large-scale testing (Phase 3)Active Not RecruitingNCT05023980
What this trial is testing

Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Loxo Oncology, Inc. 309
Post-approval studies (Phase 4)Study completedNCT00220311
What this trial is testing

Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Genzyme, a Sanofi Company 10
Testing effectiveness (Phase 2)Study completedNCT01145209
What this trial is testing

Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL

Who this might be right for
Small Lymphocytic LymphomaCLL (Chronic Lymphocytic Leukemia)
National Heart, Lung, and Blood Institute (NHLBI) 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT06637501
What this trial is testing

Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
BeOne Medicines 94
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Ended earlyNCT01980888
What this trial is testing

Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 311
Large-scale testing (Phase 3)Study completedNCT00275054
What this trial is testing

Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 825
Large-scale testing (Phase 3)Study completedNCT00931645
What this trial is testing

Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University Hospital, Caen 241
Large-scale testing (Phase 3)Study completedNCT00002766
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 170
Large-scale testing (Phase 3)Study completedNCT04008706
What this trial is testing

Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 552
Testing effectiveness (Phase 2)Looking for participantsNCT05336812
What this trial is testing

Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02427451
What this trial is testing

Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Kerry Rogers 87
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT05197192
What this trial is testing

A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 202
Large-scale testing (Phase 3)Study completedNCT00254163
What this trial is testing

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
US Oncology Research 184
Next Page